Skip to content
Inciteful Med

Understanding Hemoglobin C Disease

Last updated:

Hemoglobin C disease (HbCC) is a mild, inherited blood condition that is distinct from severe sickle cell anemia. Most people with HbCC live normal, active lives with a normal life expectancy, though they may experience mild anemia, fatigue, or an enlarged spleen.

Key Takeaways

  • • Hemoglobin C disease (HbCC) is generally a mild condition and is not a severe form of sickle cell anemia.
  • • Most people with HbCC have a normal life expectancy and can maintain an active lifestyle without major restrictions.
  • • Hemoglobin C trait (HbAC) means you are a carrier and typically experience no symptoms or negative health effects.
  • • The condition causes red blood cells to break down faster than normal, which can lead to mild anemia and an enlarged spleen.
  • • Patients with HbCC should have periodic checkups to monitor spleen health, check for gallstones, and receive a baseline eye exam.

Learning that you or your child has a “hemoglobin disease” can be frightening, especially if you have heard stories about the severity of sickle cell anemia. However, Hemoglobin C disease (HbCC) is a distinct condition that is usually much milder. Understanding the differences between these conditions can help you navigate your care with confidence rather than fear.

Hemoglobin is the protein in your red blood cells that carries oxygen throughout your body [1]. Hemoglobin C is a genetic variant of this protein. While normal hemoglobin (HbA) is smooth and flexible, Hemoglobin C can cause red blood cells to become slightly dehydrated and stiff [2][3].

Under a microscope, these cells often look like bullseyes, which doctors call target cells [4][5]. In some cases, the hemoglobin can even form tiny, rod-shaped crystals inside the cell [6]. Because these cells are not perfectly shaped, the body breaks them down faster than normal cells, a process called hemolysis (red blood cell breakdown) [7][8]. This can lead to mild anemia, where you have fewer red blood cells to carry oxygen [9][10].

Three Stabilizing Facts

If you are feeling overwhelmed by a new diagnosis, keep these three points in mind:

  1. It is usually mild: Unlike sickle cell anemia (HbSS), which can cause severe pain and organ damage starting in childhood, Hemoglobin C disease (HbCC) is not a form of sickle cell disease and is generally considered a “benign” or mild condition [11][9]. Many people with HbCC do not even know they have it until they have a routine blood test [4].
  2. Normal life expectancy: While research is ongoing, HbCC is not typically associated with a shortened lifespan or the frequent “pain crises” seen in other hemoglobin disorders [12][9].
  3. Active lifestyle is possible: Most people with HbCC can participate in sports, work, and daily activities without significant restrictions, though they may experience slightly more fatigue than others due to mild anemia [13][10].

Understanding the Different Types

It is common to confuse these terms, but they mean very different things for your health:

Type Name What it means Common Symptoms
HbAC Hemoglobin C Trait You are a “carrier.” You have one gene for Hemoglobin C and one normal gene. [14] Usually none. Most people have no health issues and normal blood counts. [15][14]
HbCC Hemoglobin C Disease You have two genes for Hemoglobin C. [9] Mild. May include mild anemia, fatigue, or a slightly enlarged spleen (splenomegaly). [10][4]
HbSC Hemoglobin SC Disease You have one gene for Hemoglobin S (sickle) and one for Hemoglobin C. [16] Moderate to Severe. This is a form of sickle cell disease. It requires more careful monitoring for pain and organ issues. [17][18]

What to Watch For

While the condition is usually mild, there are a few areas that require periodic attention:

  • Spleen Health: The spleen filters out old red blood cells. Because HbCC cells break down faster, the spleen can sometimes become enlarged (splenomegaly) [4][19].
  • Vision: In rare cases, the blood vessels in the back of the eye (retina) can be affected, similar to what happens in sickle cell disease [20]. A baseline eye exam with an ophthalmologist is recommended [20].
  • Gallstones: Chronic breakdown of red blood cells can lead to the formation of gallstones (cholelithiasis) over time [21].
  • Pregnancy: If you have HbCC and are pregnant, your care team may monitor you more closely, as there can be a slightly higher risk of complications like jaundice for the newborn [22][23].

To learn more about the specifics of your condition, explore the following pages:

Frequently Asked Questions

What is the difference between Hemoglobin C disease and sickle cell anemia?
Hemoglobin C disease (HbCC) is usually a mild condition, whereas sickle cell anemia (HbSS) can cause severe pain and organ damage. HbCC is not a form of sickle cell disease and typically allows for a normal life expectancy.
What does it mean to have Hemoglobin C trait (HbAC)?
Hemoglobin C trait means you are a carrier, inheriting one normal hemoglobin gene and one Hemoglobin C gene. Most people with the trait have no health issues, experience no symptoms, and have normal blood counts.
Will Hemoglobin C disease restrict my daily activities or lifestyle?
Most people with Hemoglobin C disease live normal, active lives and can fully participate in sports, work, and daily activities. You may experience slightly more fatigue than others due to mild anemia, but it rarely causes major disruptions.
What health complications should I watch for with Hemoglobin C disease?
Because your red blood cells break down faster than normal, you should monitor for signs of an enlarged spleen, gallstones, and mild anemia. It is also recommended to get a baseline eye exam, as vision issues can occur in rare cases.
Should my family members be tested for Hemoglobin C?
Yes, because Hemoglobin C is an inherited genetic condition. Your partner or family members may want to be tested for hemoglobin traits to understand their carrier status, which is especially important if you are planning to have children.

Questions for Your Doctor

  • • Can you confirm if my diagnosis is HbAC, HbCC, or HbSC based on my test results?
  • • What is my baseline hemoglobin level, and how does it compare to the normal range?
  • • Since I have Hemoglobin C Disease, are you certain I am not misdiagnosed with iron deficiency anemia?
  • • Does my spleen appear enlarged, and what signs of 'splenomegaly' should I watch for at home?
  • • Should my partner or other family members be tested for hemoglobin traits?

Questions for You

  • • What were the specific symptoms (like fatigue or yellowing of the eyes) that led to this diagnosis?
  • • Does anyone else in my family have a history of anemia or gallbladder issues?
  • • How would I describe my typical energy levels on a daily basis?
  • • Have I ever noticed a feeling of fullness or pain in the upper left side of my abdomen?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Genome-wide association study of erythrocyte density in sickle cell disease patients.

    Ilboudo Y, Bartolucci P, Rivera A, et al.

    Blood cells, molecules & diseases 2017; (65()):60-65 doi:10.1016/j.bcmd.2017.05.005.

    PMID: 28552477
  2. 2

    Hemoglobin Genotypes Modulate Inflammatory Response to Plasmodium Infection.

    Harp KO, Botchway F, Dei-Adomakoh Y, et al.

    Frontiers in immunology 2020; (11()):593546 doi:10.3389/fimmu.2020.593546.

    PMID: 33424841
  3. 3

    Herbal Drug use in Sickle Cell Disease Management; Trends and Perspectives in Sub-Saharan Africa - A Systematic Review.

    Okoh MP, Alli LA, Tolvanen MEE, Nwegbu MM

    Current drug discovery technologies 2019; (16(4)):372-385 doi:10.2174/1570163815666181002101611.

    PMID: 30277160
  4. 4

    Hemoglobinosis C in Morocco : A report of 111 cas.

    Ouzzif Z, El Maataoui A, Oukhedda N, et al.

    La Tunisie medicale 2017; (95(12)):229-233.

    PMID: 29878289
  5. 5

    An incidental finding of a hemoglobin E variant in a diabetic patient with an abnormal glycated hemoglobin level: a case report.

    Karki R, Lamichhane S, Jha R, Manandhar R

    Journal of medical case reports 2024; (18(1)):279 doi:10.1186/s13256-024-04518-y.

    PMID: 38877536
  6. 6

    Rod-Shaped Hemoglobin Crystals: Clues to the Diagnosis of Hemoglobin C Disease.

    Xu K, Zhao J, Dramé BSI, et al.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2024; (40(2)):368-369 doi:10.1007/s12288-023-01713-7.

    PMID: 38708168
  7. 7

    Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.

    Jacobs JW, Sharma D, Stephens LD, et al.

    British journal of haematology 2024; (204(4)):1500-1506 doi:10.1111/bjh.19313.

    PMID: 38291731
  8. 8

    [Diagnosis of non-autoimmune hemolysis in the adult].

    Ruivard M, Michel M, Garçon L

    La Revue de medecine interne 2025; (46(12)):725-732 doi:10.1016/j.revmed.2025.08.001.

    PMID: 40930929
  9. 9

    Regional Prevalence of Hemoglobin C Across Saudi Arabia: An Epidemiological Survey.

    Aljabry M, Sulimani S, Alotaibi G, et al.

    Journal of epidemiology and global health 2024; (14(2)):298-303 doi:10.1007/s44197-024-00193-w.

    PMID: 38372896
  10. 10

    Hemoglobin C Disorder in Anemic Patients Referred to the National Center for Thalassemia and Genetic Counseling in Damascus.

    Ahmad A, Fattoum K, Imam W, et al.

    International journal of hematology-oncology and stem cell research 2024; (18(2)):183-191 doi:10.18502/ijhoscr.v18i2.15376.

    PMID: 38868813
  11. 11

    Management of Sickle Cell Disease in Children.

    Noronha SA, Sadreameli SC, Strouse JJ

    Southern medical journal 2016; (109(9)):495-502 doi:10.14423/SMJ.0000000000000523.

    PMID: 27598348
  12. 12

    Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.

    The Lancet. Haematology 2023; (10(8)):e585-e599 doi:10.1016/S2352-3026(23)00118-7.

    PMID: 37331373
  13. 13

    Impact of a submaximal mono-articular exercise on the skeletal muscle function of patients with sickle cell disease.

    Gouraud E, Connes P, Gauthier-Vasserot A, et al.

    European journal of applied physiology 2021; (121(9)):2459-2470 doi:10.1007/s00421-021-04716-2.

    PMID: 34023973
  14. 14

    Compound heterozygosity for Hb C/Hb S (HBB: c.19G>A/HBB: c.20A>T) diseases observed in a Syrian family: a case report.

    Moassas F, Daboul A, Assád M, Murad H

    Annals of medicine and surgery (2012) 2023; (85(4)):1184-1187 doi:10.1097/MS9.0000000000000386.

    PMID: 37113902
  15. 15

    Association between sickle cell and β-thalassemia genes and hemoglobin concentration and anemia in children and non-pregnant women in Sierra Leone: ancillary analysis of data from Sierra Leone's 2013 National Micronutrient Survey.

    Wirth JP, Ansumana R, Woodruff BA, et al.

    BMC research notes 2018; (11(1)):43 doi:10.1186/s13104-018-3143-x.

    PMID: 29343300
  16. 16

    A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.

    Setayesh T, Chi M, Oestreicher Z, et al.

    Blood 2025; (146(1)):13-28 doi:10.1182/blood.2024028136.

    PMID: 40324066
  17. 17

    Gene therapy for HbSC disease and other compound heterozygous sickle hemoglobinopathies: a time for inclusion.

    Wilks A, Steinberg MH, Frangoul H

    Blood 2025; (146(20)):2385-2391 doi:10.1182/blood.2025029964.

    PMID: 40834880
  18. 18

    Atypical Overt Hemorrhagic Stroke in an Adult With Sickle Cell-Hemoglobin C Disease: A Report of a Rare Case.

    Manjrekar NS, Preisig AM, Singh C, Rezwan M

    Cureus 2026; (18(1)):e100573 doi:10.7759/cureus.100573.

    PMID: 41625049
  19. 19

    Uncommon Presentation of Hypersplenism in Adult Sickle Cell Disease Patients: A Rare Case Report.

    Qureshi A, Kasbawala K, Santos MT, et al.

    The American journal of case reports 2024; (25()):e944693 doi:10.12659/AJCR.944693.

    PMID: 39300742
  20. 20

    Tractional Retinal Detachment Related to Hemoglobin C Trait Retinopathy: A Case Report.

    Garrell-Salat X, Garcia-Arumi C, Bertolani Y, et al.

    Turkish journal of ophthalmology 2023; (53(5)):318-321 doi:10.4274/tjo.galenos.2023.48672.

    PMID: 37870045
  21. 21

    Prevalence of Cardiovascular Complications in Individuals with Sickle Cell Anemia and Other Hemoglobinopathies: A Systematic Review.

    Lopes A, Dantas MT, Ladeia AMT

    Arquivos brasileiros de cardiologia 2022; (119(6)):893-899 doi:10.36660/abc.20220207.

    PMID: 36417618
  22. 22

    Biomarkers of oxidative stress and its nexus with haemoglobin variants and adverse foeto-maternal outcome among women with preeclampsia in a Ghanaian population: A multi-centre prospective study.

    Abdul G, Osei-Wusu W, Asare GA, et al.

    PloS one 2023; (18(3)):e0283638 doi:10.1371/journal.pone.0283638.

    PMID: 36996011
  23. 23

    The effects of exchange transfusion for prevention of complications during pregnancy of sickle hemoglobin C disease patients.

    Benites BD, Benevides TC, Valente IS, et al.

    Transfusion 2016; (56(1)):119-24 doi:10.1111/trf.13280.

    PMID: 26337929

This page provides general educational information about Hemoglobin C disease and its traits. Always consult your hematologist or primary care doctor for an accurate diagnosis, blood test interpretation, and personalized medical advice.

Stay up to date

Get notified when new research about Hemoglobin C disease is published.

No spam. Unsubscribe anytime.